Immunotherapy Biomarkers: Overcoming the Barriers Symposium - Defining New Metrics of Immune Competence by CyTOFApril 2016Bethesda, MDSummaryIn this slide presentation from "Immunotherapy Biomarkers: Overcoming the Barriers" Symposium in Bethesda MD in April 2016, Dr. Holden Maecker, PhD (Associate Professor, Stanford Medicine) explains the use of mass cytometry (CyTOF) to measure immunocompetence.Disclaimer: Due to the rapidly-evolving field of cancer immunotherapy, some of the content on this page may be out of date. For current information from SITC on cancer immunotherapy, scroll down to view Related Entries and Links.#Industry#Video #Oncologist #Biomarkers #Pharmacist #Researcher #Clinician #AlliedHealth
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us